Alnylam Pharmaceuticals
ALNY
#642
Rank
$31.91 B
Marketcap
$243.53
Share price
-1.30%
Change (1 day)
62.31%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company